Biography

Christina Ackermann joined the company as Executive Vice President, General Counsel, in August 2016. In this role, she is responsible for Bausch Health’s worldwide legal affairs, compliance, global security and enterprise risk management.  

Prior to Bausch Health,  Ackermann was part of the Novartis group of companies for 14 years, most recently serving as Senior Vice President, General Counsel for Alcon, where she was responsible for the for the legal, intellectual property and compliance functions.

Previously, she served as Global Head, Legal and General Counsel at Sandoz, the generics division of Novartis, from 2007 to 2012. She joined Novartis Pharma in 2002 as Head, Legal Technical Operations and Ophthalmics, and assumed the role of Head Legal General Medicine in July 2005.

Before Novartis, Ackermann served in Associate General Counsel roles with Bristol Myers Squibb and DuPont Pharmaceuticals, as well as in private practice, where she focused on securities, and mergers & acquisitions.

Ackermann attended York University, Toronto, Canada, for her undergraduate studies, focusing initially on fine arts and later moving into mathematics and political sciences. Ackermann also attended Queen's University, Kingston, Canada, where she obtained her LL.B., and King’s College at the University of London, UK, where she obtained a Post Graduate Diploma in EC Competition Law.

Associated Items

1 item
Date
Program or Publication
Format